Optime Care, a nationally recognized specialty pharmacy and an AscellaHealth Company, today announces an expanded partnership ...

Eton expects to significantly expand patient access to this critical treatment for Wilson disease patients –– $0 co-pay for ...

In 4 of 16 patients (Cases 1, 4, 6 and 7) granulocytopenia developed during the course of treatment with D,L-DOPA. Two episodes were rapid, and 2 gradual, the latter occurring over several months.

ST. LOUIS, March 04, 2025 (GLOBE NEWSWIRE) -- Optime Care, a nationally recognized specialty pharmacy and an AscellaHealth Company, today announces an expanded partnership with Eton ...

The cases reported the following complications of copper deficiency: anemia, granulocytopenia, leukopenia, neutropenia, pancytopenia, thrombocytopenia, and myeloneuropathy. If a patient develops ...

Thrombocytopenia, which is a low platelet count, can be caused by problems in the bone marrow or the immune system. The bone marrow may not make enough platelets, or the immune system may destroy ...